发明名称 USE OF THERAPEUTIC PEPTIDES FOR THE TREATMENT AND PREVENTION OF CANCER
摘要 MUC1 (DF3, CD227, episialin, PEM) is a heavily O-glycosylated heterodimeric protein of >300 kDa, normally expressed abundantly on the apical surface of glandular epithelia. MUC1 mimetic peptides are selectively retained in mammary gland tumors, colon and skin after systemic administration. Moreover, MUC1 mimetic peptides reduce tumor initiation. In addition, MUC1 mimetic peptides can be used in conjunction with other anti-EGFR treatments in the adjuvant context, i.e., after surgery.
申请公布号 US2011014195(A1) 申请公布日期 2011.01.20
申请号 US20090867396 申请日期 2009.02.19
申请人 ARIZONA BIOMEDICAL RESEARCH COMMISSION 发明人 SCHROEDER JOYCE A.
分类号 A61K39/395;A61K38/10;A61P35/00 主分类号 A61K39/395
代理机构 代理人
主权项
地址